Sort
15,842 grants matching “pancreatic cancer”
Center for Functional Validation and Evaluation of ENCODE Enhancer Regions, Grant Number 5UM1HG009426-03
$443,573Jennifer Robin Moran · Tempus Labs, Inc. · UM1 · FY2020 · HG
Targeting Acquired Resistance in KRAS Driven Cancers
$443,465Wantong Yao · University Of Tx Md Anderson Can Ctr · R37 · FY2022 · CA
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model
$443,445David Charles Lyden · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
Project 3: The AMPK Autophagy Pathway as a Metabolic Liability in Pancratic Ductal Adenocarcinoma
$443,412Reuben J Shaw · Salk Institute For Biological Studies · P01 · FY2024 · CA
Transcription Factor Mutants of Yeast
$443,333Karen M Arndt · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · GM
Project 3: Impact of tumor genetics on PDAC immunobiology and responses to macrophage-targeted immunotherapy
$443,282Edgar G. Engleman · Stanford University · P01 · FY2021 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$443,259David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
$443,233Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
$443,233Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
A Pathway of Tumor Suppression
$443,233Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Biology and Immunology of Pancreatic Cancer Stem Cells in a Novel Mouse Model
$443,110Edgar G. Engleman · Stanford University · U01 · FY2013 · CA
Function of IL35+ B cells in pancreatic cancer
$443,047Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2022 · CA
Metabolic flux analysis and PDX models to understand therapeutic vulnerabilities following inhibition of Ref-1 redox signaling in pancreatic cancer
$443,001Mark R. Kelley · Indiana University Indianapolis · R01 · FY2024 · CA
The Ohio State University Pancreatic Disorders Network (OSU-PDN)
$442,874Darwin Lewis Conwell · Ohio State University · U01 · FY2017 · DK
Highly Sensitive Detection of Occult Pancreatic Cancer Using Intraoperative Molecular Imaging
$442,872George Poultsides · Stanford University · R01 · FY2024 · CA
Regulation of Nutrient Stress-Induced Macropinocytosis in Pancreatic Ductal Adenocarcinoma
$442,829Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · CA
Cancer under pressure: Mechanisms of adaptation to compressive stress
$442,709Liam J Holt · New York University School Of Medicine · R37 · FY2024 · CA
Stimuli-responsive mucin1-specific nanoparticles for efficacious combinatorial chemotherapy of pancreatic ductal adenocarcinoma
$442,634Juan Luis Vivero-Escoto · University Of North Carolina Charlotte · R01 · FY2024 · CA
Core 1: Tumor and Microenvironment Heterogeneity Core (TMH Core)
$442,567Susan M Kaech · Salk Institute For Biological Studies · P01 · FY2023 · CA
Defining the roles of RIPK1 and RIPK3 in emergency hematopoiesis
$442,500Ben Adam Croker · Boston Children'S Hospital · R01 · FY2016 · HL
Defining the roles of RIPK1 and RIPK3 in emergency hematopoiesis
$442,500Ben Adam Croker · Boston Children'S Hospital · R01 · FY2017 · HL
Leveraging deep learning for markerless motion management in radiation therapy
$442,403Lei Xing · Stanford University · R01 · FY2021 · CA
Glutamine synthetase in cancer cell metabolism and oncogenesis
$442,333Wei-Xing Zong · Rutgers Biomedical And Health Sciences · R01 · FY2022 · CA
Surgical and Animal Core
$442,242Dai Fukumura · Massachusetts General Hospital · P01 · FY2015 · CA
Real-time monitoring of circulating pancreatic tumor cells and clusters
$442,133Erica Carpenter · University Of Pennsylvania · R01 · FY2018 · CA